government to rebalance the global system, expand access and lower costs for Americans while also protecting our company's ability to both innovate and enhance manufacturing capacity to meet the significant demand for our life-saving medicines." Sources Lilly and U.S
Thanks to the introduction of the GLP-1 (glucagon-like peptide-1) class of drugs and the dramatic results theyve had on society, the introduction of continuous glucose monitoring devices, insulin pumps, and health care costs associated with diabetes drugs decreasing, diabetes is finally starting to the draw national attention weve long thought it deserved, said Scientific Sessions Meeting Planning Committee Chair Mark A
Patients should keep a symptom diary if constipation is persistent and discuss any concerns during routine diabetes reviews
Medication that has been compromised by temperature extremes may not deliver consistent results regardless of injection technique
PubMed Central , Neuro Endocrinology Letters , vol